Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program Research Triangle Park, NC, USA and Cambridge, UK, 11 January 2022 -- Inivata, a leader...

Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer Prospective, interventional study...

Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test  Inivata publishes positive clinical validation results and real-world utility for its  InVisionFirst®-Lung liquid biopsy test  InVisionFirst®-Lung demonstrated excellent concordance with tissue...